Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1.

Tiendrebeogo RW, Spallek R, Oehlmann W, Singh M, Theisen M, Nebie I, Moret R, Roussilhon C, Corradin G.

Vaccine. 2019 Aug 23;37(36):5332-5340. doi: 10.1016/j.vaccine.2019.07.048. Epub 2019 Jul 26.

PMID:
31358409
2.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.

Barry A, Behet MC, Nébié I, Lanke K, Grignard L, Ouedraogo A, Soulama I, Drakeley C, Sauerwein R, Bolscher JM, Dechering KJ, Bousema T, Tiono AB, Gonçalves BP.

Version 2. Wellcome Open Res. 2019 May 1 [revised 2019 Jan 1];3:159. doi: 10.12688/wellcomeopenres.14932.2. eCollection 2018.

3.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.

Grignard L, Mair C, Curry J, Mahey L, Bastiaens GJH, Tiono AB, Okebe J, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Lanke KHW, Sirima SB, d'Alessandro U, Clark TG, Campino S, Bousema T, Drakeley C.

Malar J. 2019 Jan 21;18(1):14. doi: 10.1186/s12936-019-2648-7.

4.

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, Roberts R, Rampling T, Bliss C, Hodgson S, Lawrie A, Ouedraogo A, Imoukhuede EB, Ewer KJ, Viebig NK, Diarra A, Leroy O, Bejon P, Hill AVS, Sirima SB.

PLoS One. 2018 Dec 12;13(12):e0208328. doi: 10.1371/journal.pone.0208328. eCollection 2018.

5.

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding.

Grignard L, Gonçalves BP, Early AM, Daniels RF, Tiono AB, Guelbéogo WM, Ouédraogo A, van Veen EM, Lanke K, Diarra A, Nebie I, Sirima SB, Targett GA, Volkman SK, Neafsey DE, Wirth DF, Bousema T, Drakeley C.

Int J Parasitol. 2018 Jul;48(8):671-677. doi: 10.1016/j.ijpara.2018.02.005. Epub 2018 May 5.

6.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Bradley J, Lanke KHW, Niemi M, Sirima SB, d'Alessandro U, Bousema T, Drakeley C.

PLoS One. 2018 Jan 11;13(1):e0190272. doi: 10.1371/journal.pone.0190272. eCollection 2018.

7.

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.

Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, Stone W, Hellewell J, Lanke K, Bastiaens GJH, Bradley J, Nébié I, Ngoi JM, Oriango R, Mkabili D, Nyaurah M, Midega J, Wirth DF, Marsh K, Churcher TS, Bejon P, Sirima SB, Drakeley C, Bousema T.

Nat Commun. 2017 Oct 26;8(1):1133. doi: 10.1038/s41467-017-01270-4.

8.

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.

Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebié I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group.

Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22.

PMID:
28947345
9.

Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria.

Quin JE, Bujila I, Chérif M, Sanou GS, Qu Y, Vafa Homann M, Rolicka A, Sirima SB, O'Connell MA, Lennartsson A, Troye-Blomberg M, Nebie I, Östlund Farrants AK.

Elife. 2017 Sep 19;6. pii: e29156. doi: 10.7554/eLife.29156.

10.

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.

Cherif MK, Ouédraogo O, Sanou GS, Diarra A, Ouédraogo A, Tiono A, Cavanagh DR, Michael T, Konaté AT, Watson NL, Sanza M, Dube TJT, Sirima SB, Nebié I.

BMC Res Notes. 2017 Sep 8;10(1):472. doi: 10.1186/s13104-017-2772-9.

11.

The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.

Karch CP, Doll TAPF, Paulillo SM, Nebie I, Lanar DE, Corradin G, Burkhard P.

J Nanobiotechnology. 2017 Sep 6;15(1):62. doi: 10.1186/s12951-017-0295-0.

12.

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.

Tadesse FG, Lanke K, Nebie I, Schildkraut JA, Gonçalves BP, Tiono AB, Sauerwein R, Drakeley C, Bousema T, Rijpma SR.

Am J Trop Med Hyg. 2017 Jul;97(1):188-198. doi: 10.4269/ajtmh.16-0893.

13.

Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.

Céspedes N, Li Wai Suen CSN, Koepfli C, França CT, Felger I, Nebie I, Arévalo-Herrera M, Mueller I, Corradin G, Herrera S.

PLoS One. 2017 Jun 26;12(6):e0179863. doi: 10.1371/journal.pone.0179863. eCollection 2017.

14.

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.

Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ.

Mol Ther. 2017 Feb 1;25(2):547-559. doi: 10.1016/j.ymthe.2016.11.003.

15.

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.

Pett H, Gonçalves BP, Dicko A, Nébié I, Tiono AB, Lanke K, Bradley J, Chen I, Diawara H, Mahamar A, Soumare HM, Traore SF, Baber I, Sirima SB, Sauerwein R, Brown J, Gosling R, Felger I, Drakeley C, Bousema T.

Malar J. 2016 Nov 8;15(1):539.

16.

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.

Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nébié I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima SB.

Mol Ther. 2016 Aug;24(8):1470-7. doi: 10.1038/mt.2016.83. Epub 2016 Apr 25.

17.

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.

Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, Drakeley C, Bousema T.

BMC Med. 2016 Mar 8;14:40. doi: 10.1186/s12916-016-0581-y.

18.

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Adu B, Cherif MK, Bosomprah S, Diarra A, Arthur FK, Dickson EK, Corradin G, Cavanagh DR, Theisen M, Sirima SB, Nebie I, Dodoo D.

Malar J. 2016 Feb 27;15:123. doi: 10.1186/s12936-016-1146-4.

19.

Distribution of FcγR gene polymorphisms among two sympatric populations in Mali: differing allele frequencies, associations with malariometric indices and implications for genetic susceptibility to malaria.

Cherif M, Amoako-Sakyi D, Dolo A, Pearson JO, Gyan B, Obiri-Yeboah D, Nebie I, Sirima SB, Doumbo O, Troye-Blomberg M, Bakary M.

Malar J. 2016 Jan 19;15:29. doi: 10.1186/s12936-015-1082-8.

20.

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso.

Soulama I, Sermé SS, Bougouma EC, Diarra A, Tiono AB, Ouedraogo A, Konate AT, Nebie I, Sirima SB.

J Parasitol Res. 2015;2015:985651. doi: 10.1155/2015/985651. Epub 2015 Nov 8.

21.

Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.

Kangoye DT, Mensah VA, Murungi LM, Nkumama I, Nebie I, Marsh K, Cisse B, Bejon P, Osier FH, Sirima SB; MVVC Infant Immunology Study Group.

Vaccine. 2016 Jan 2;34(1):160-6. doi: 10.1016/j.vaccine.2015.10.058. Epub 2015 Nov 11.

22.

Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children.

Tiendrebeogo RW, Adu B, Singh SK, Dziegiel MH, Nébié I, Sirima SB, Christiansen M, Dodoo D, Theisen M.

Open Forum Infect Dis. 2015 Apr 10;2(2):ofv044. doi: 10.1093/ofid/ofv044. eCollection 2015 Apr.

23.

Malaria Vaccines: Progressing on a Bumpy Road.

Corradin G, Nebie I.

EBioMedicine. 2014 Oct 23;1(1):6-7. doi: 10.1016/j.ebiom.2014.10.010. eCollection 2014 Nov. No abstract available.

24.

Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.

Jones S, Grignard L, Nebie I, Chilongola J, Dodoo D, Sauerwein R, Theisen M, Roeffen W, Singh SK, Singh RK, Singh S, Kyei-Baafour E, Tetteh K, Drakeley C, Bousema T.

J Infect. 2015 Jul;71(1):117-27. doi: 10.1016/j.jinf.2015.03.007. Epub 2015 Apr 11.

PMID:
25869538
25.

Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia.

Mangano VD, Kabore Y, Bougouma EC, Verra F, Sepulveda N, Bisseye C, Santolamazza F, Avellino P, Tiono AB, Diarra A, Nebie I, Rockett KA, Sirima SB, Modiano D; MalariaGEN Consortium.

J Infect Dis. 2015 Aug 15;212(4):626-34. doi: 10.1093/infdis/jiv098. Epub 2015 Feb 23.

26.

Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.

Balam S, Olugbile S, Servis C, Diakité M, D'Alessandro A, Frank G, Moret R, Nebie I, Tanner M, Felger I, Smith T, Kajava AV, Spertini F, Corradin G.

Malar J. 2014 Dec 19;13:510. doi: 10.1186/1475-2875-13-510.

27.

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

Cherif MK, Sanou GS, Bougouma EC, Diarra A, Ouédraogo A, Dolo A, Troye-Blomberg M, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Acta Trop. 2015 Feb;142:41-6. doi: 10.1016/j.actatropica.2014.09.019. Epub 2014 Oct 31.

PMID:
25447268
28.

Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors.

Rizzo C, Lombardo F, Ronca R, Mangano V, Sirima SB, Nèbiè I, Fiorentino G, Modiano D, Arcà B.

Parasit Vectors. 2014 Nov 28;7:549. doi: 10.1186/s13071-014-0549-8.

29.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T.

Clin Infect Dis. 2015 Feb 1;60(3):357-65. doi: 10.1093/cid/ciu797. Epub 2014 Nov 19. Erratum in: Clin Infect Dis. 2016 Sep 1;63(5):715.

PMID:
25414262
30.

High-throughput tri-colour flow cytometry technique to assess Plasmodium falciparum parasitaemia in bioassays.

Tiendrebeogo RW, Adu B, Singh SK, Dodoo D, Dziegiel MH, Mordmüller B, Nébié I, Sirima SB, Christiansen M, Theisen M.

Malar J. 2014 Oct 20;13:412. doi: 10.1186/1475-2875-13-412.

31.

[Laboratory test features of newly diagnosed adult HIV-infected patients in Ouagadougou (Burkina Faso)].

Sagna Y, Koulidiaty J, Diallo I, Sanou AF, Bagbila PA, Sagna T, Nébié I, Guira O, Tiéno H, Drabo YJ.

Med Sante Trop. 2014 Jul-Sep;24(3):307-11. doi: 10.1684/mst.2014.0381. French.

32.

Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).

Kangoye DT, Nebie I, Yaro JB, Debe S, Traore S, Ouedraogo O, Sanou G, Soulama I, Diarra A, Tiono A, Marsh K, Sirima SB, Bejon P.

PLoS One. 2014 Sep 19;9(9):e107965. doi: 10.1371/journal.pone.0107965. eCollection 2014.

33.

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial.

Tiono AB, Diarra A, Sanon S, Nébié I, Konaté AT, Pagnoni F, Sirima SB.

Infect Dis Ther. 2013 Dec;2(2):227. doi: 10.1007/s40121-013-0017-3. No abstract available.

34.

IgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.

Rizzo C, Ronca R, Lombardo F, Mangano V, Sirima SB, Nèbiè I, Fiorentino G, Troye-Blomberg M, Modiano D, Arcà B.

PLoS One. 2014 Apr 23;9(4):e96130. doi: 10.1371/journal.pone.0096130. eCollection 2014.

35.

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.

Nébié I, Edwards NJ, Tiono AB, Ewer KJ, Sanou GS, Soulama I, Sanon S, Diarra A, Yaro JB, Kangoye D, Imoukhuede EB, Hill AV, Sirima SB.

Clin Vaccine Immunol. 2014 Jun;21(6):901-3. doi: 10.1128/CVI.00723-13. Epub 2014 Apr 16. Erratum in: Clin Vaccine Immunol. 2014 Sep;21(9):1376.

36.

Paracheck® rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso.

Samadoulougou S, Kirakoya-Samadoulougou F, Sarrassat S, Tinto H, Bakiono F, Nebié I, Robert A.

Malar J. 2014 Mar 17;13:101. doi: 10.1186/1475-2875-13-101.

37.

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.

Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kaboré Y, Diarra A, Ouedraogo E, Nébié I, Ouédraogo A, Okech B, Milligan P, Sirima SB.

PLoS One. 2014 Jan 24;9(1):e86936. doi: 10.1371/journal.pone.0086936. eCollection 2014.

38.

In vitro antiplasmodial activity of some medicinal plants of Burkina Faso.

Ouattara LP, Sanon S, Mahiou-Leddet V, Gansané A, Baghdikian B, Traoré A, Nébié I, Traoré AS, Azas N, Ollivier E, Sirima SB.

Parasitol Res. 2014 Jan;113(1):405-16. doi: 10.1007/s00436-013-3669-8. Epub 2013 Dec 8.

PMID:
24318747
39.

A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB.

PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013.

41.

Low specificity of a malaria rapid diagnostic test during an integrated community case management trial.

Tiono AB, Diarra A, Sanon S, Nébié I, Konaté AT, Pagnoni F, Sirima SB.

Infect Dis Ther. 2013 Jun;2(1):27-36. doi: 10.1007/s40121-013-0006-6. Epub 2013 May 29.

42.

Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.

Ouédraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, Bougouma EC, Soulama I, Gansané A, Ouedraogo A, Konate AT, Nebie I, Watson NL, Sanza M, Dube TJ, Sirima SB.

PLoS One. 2013;8(1):e50036. doi: 10.1371/journal.pone.0050036. Epub 2013 Jan 8.

43.

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso.

Diarra A, Nébié I, Tiono A, Sanon S, Soulama I, Ouédraogo A, Gansané A, Yaro JB, Ouédraogo E, Traoré AS, Sirima SB.

Parasit Vectors. 2012 May 30;5:103. doi: 10.1186/1756-3305-5-103.

44.

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso.

Bougouma EC, Tiono AB, Ouédraogo A, Soulama I, Diarra A, Yaro JB, Ouédraogo E, Sanon S, Konaté AT, Nébié I, Watson NL, Sanza M, Dube TJ, Sirima SB.

Malar J. 2012 May 4;11:154. doi: 10.1186/1475-2875-11-154.

45.

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.

Diarra A, Nebie I, Tiono A, Soulama I, Ouedraogo A, Konate A, Theisen M, Dodoo D, Traore A, Sirima SB.

Malar J. 2012 Mar 22;11:79. doi: 10.1186/1475-2875-11-79.

46.

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.

Sanou GS, Tiendrebeogo RW, Ouédraogo AL, Diarra A, Ouédraogo A, Yaro JB, Ouédraogo E, Verra F, Behr C, Troye-Blomberg M, Modiano D, Dolo A, Torcia MG, Traoré Y, Sirima SB, Nébié I.

BMC Res Notes. 2012 Jan 27;5:76. doi: 10.1186/1756-0500-5-76.

47.

FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.

Cherif MK, Sanou GS, Maiga B, Israelsson E, Ouédraogo AL, Bougouma EC, Diarra A, Ouédraogo A, Ouattara AS, Troye-Blomberg M, Dolo A, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Scand J Immunol. 2012 Jun;75(6):606-13. doi: 10.1111/j.1365-3083.2012.02690.x.

48.

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso.

Ouédraogo A, Tiono AB, Diarra A, Bougouma EC, Nébié I, Konaté AT, Sirima SB.

J Trop Med. 2012;2012:109705. doi: 10.1155/2012/109705. Epub 2011 Nov 30.

49.

Human genetic variation is associated with Plasmodium falciparum drug resistance.

Paganotti GM, Gallo BC, Verra F, Sirima BS, Nebié I, Diarra A, Coluzzi M, Modiano D.

J Infect Dis. 2011 Dec 1;204(11):1772-8. doi: 10.1093/infdis/jir629. Epub 2011 Oct 12.

PMID:
21998472
50.

Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Ouédraogo AL, Roeffen W, Luty AJ, de Vlas SJ, Nebie I, Ilboudo-Sanogo E, Cuzin-Ouattara N, Teleen K, Tiono AB, Sirima SB, Verhave JP, Bousema T, Sauerwein R.

Infect Immun. 2011 Dec;79(12):4957-64. doi: 10.1128/IAI.05288-11. Epub 2011 Oct 3.

Supplemental Content

Support Center